These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1773301)

  • 1. Oxybutynin and incontinence during grand mal seizures.
    Harari D; Malone-Lee JG
    Br J Urol; 1991 Dec; 68(6):658. PubMed ID: 1773301
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxybutynin chloride in the management of idiopathic detrusor instability.
    Paulson DF
    South Med J; 1979 Mar; 72(3):374-5. PubMed ID: 424842
    [No Abstract]   [Full Text] [Related]  

  • 3. Tethered cord syndrome in an adult. Pharmacological treatment of the urological symptomatology by oxybutynin.
    De Angelis M; Martina G; Caverni L; Coglitore A; Libanori GP; Giannotti P
    Acta Urol Belg; 1986; 54(1):99-105. PubMed ID: 3962800
    [No Abstract]   [Full Text] [Related]  

  • 4. [Instability of the detrusor muscle. Treatment with oxybutynin chloride (ditropan)].
    Perales Cabanas L; Tallada Buñuel M; Romero Maroto J; Escribano Patiño G
    Actas Urol Esp; 1986; 10(6):481-6. PubMed ID: 3825651
    [No Abstract]   [Full Text] [Related]  

  • 5. Terodiline and oxybutynin in detrusor instability.
    Drug Ther Bull; 1988 May; 26(10):37-8. PubMed ID: 3383752
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oxybutynin chloride in pediatrics: extenuating circumstances].
    Aubert D
    Arch Fr Pediatr; 1988 May; 45(5):375-6. PubMed ID: 3415420
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of detrusor instability in postmenopausal women with oxybutynin chloride: a double blind placebo controlled study.
    Moore KH; Goldstein M; Hay D
    Br J Obstet Gynaecol; 1990 Nov; 97(11):1063-4. PubMed ID: 2082973
    [No Abstract]   [Full Text] [Related]  

  • 8. Ambulant monitoring to assess the efficacy of oxybutynin chloride in patients with mixed incontinence.
    van Waalwijk van Doorn ES; Zwiers W
    Eur Urol; 1990; 18(1):49-51. PubMed ID: 2401307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxybutynin hydrochloride in the management of detrusor instability.
    Primus G; Pummer K
    Int Urol Nephrol; 1990; 22(3):243-8. PubMed ID: 2210980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Topical treatment with oxybutynin chloride in neurogenic incontinence].
    López Pereira P; Martínez MJ; Muguerza R; Jaureguizar E
    Cir Pediatr; 1993 Jan; 6(1):29-31. PubMed ID: 8499234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxybutynin chloride for geriatric urinary dysfunction: a double-blind placebo-controlled study.
    Zorzitto ML; Holliday PJ; Jewett MA; Herschorn S; Fernie GR
    Age Ageing; 1989 May; 18(3):195-200. PubMed ID: 2675580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of Ditropan in the elderly: nursing responsibilities.
    Anderson CL
    Perspectives; 1993; 17(3):11. PubMed ID: 8116314
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of intravesical oxybutynin chloride in children with neurogenic bladder.
    Greenfield SP; Fera M
    J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical oxybutynin chloride: experience with 42 patients.
    Weese DL; Roskamp DA; Leach GE; Zimmern PE
    Urology; 1993 Jun; 41(6):527-30. PubMed ID: 8516987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study.
    Tapp AJ; Cardozo LD; Versi E; Cooper D
    Br J Obstet Gynaecol; 1990 Jun; 97(6):521-6. PubMed ID: 2198921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? A placebo-controlled trial.
    Ouslander JG; Schnelle JF; Uman G; Fingold S; Nigam JG; Tuico E; Jensen BB
    J Am Geriatr Soc; 1995 Jun; 43(6):610-7. PubMed ID: 7775717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of overactive bladder.
    Rackley R; Wein A; Nelson D
    Mayo Clin Proc; 2001 Nov; 76(11):1179-80. PubMed ID: 11702910
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistence of detrusor hyperreflexia in a continent, institutionalized elderly patient with Parkinson's disease.
    Starer P; Libow LS
    N Y State J Med; 1991 Apr; 91(4):166-7. PubMed ID: 2047037
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.
    Gupta SK; Sathyan G; Lindemulder EA; Ho PL; Sheiner LB; Aarons L
    Clin Pharmacol Ther; 1999 Jun; 65(6):672-84. PubMed ID: 10391673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.